期刊文献+

糖化血红蛋白和C-反应蛋白与冠状动脉病变的相关性

To study the Correlation between Serum Level of HbA1c and CRP and the Coronary Lesions in Patients with Coronary Heart Disease
下载PDF
导出
摘要 目的探讨冠心病患者冠状动脉病变程度与血清糖化血红蛋白(HbA1c)、C-反应蛋白(CRP)水平之间的关系及其临床意义。方法 293例患者按照冠状动脉造影结果分为冠心病组及非冠心病组。冠心病组根据冠状动脉病变支数分为单支病变组、双支病变组、多支病变组,并根据Gensini积分对冠状动脉病变程度进行评分并分级,分析糖化血红蛋白及C-反应蛋白水平与冠状动脉病变的相关性。结果冠心病组血清CRP及HbA1c水平明显高于非冠心病组[(4.93±8.05)mg/L vs(2.21±2.70)mg/L,(5.73±1.28)%vs(5.28±0.78)%],差异均有统计学意义(P<0.05)。年龄、低密度脂蛋白、CRP及HbA1c与冠心病密切相关(OR=1.05~2.36,均P<0.05)。冠心病组CRP及HbA1c水平与Gensini积分呈正相关(r=0.12~0.15,均P<0.05)。结论 CRP及HbA1c联合检测对冠状动脉病变程度有较高的预测价值。 Objective To study the correlation between the level of serum glycated hemoglobin (HbAlc), C-reactie protein (CRP) and the coronary lesions in patients with coronary heart disease. Methods 293 patients were divided into coronary heart disease (CHD) group(n = 229) and the normal control group (n = 64) to compare the level of HbAlc and CRF according to angiography re- suits. The Gensini score was used to evaluate the severity of coronary stenosis, and the CHD group was divided into three groups a- gain: single-artery lesions, double-artery lesions and multi-artery lesions. The coronary lesions was rated and classified by Gensini score, and the correlation between HbAlc and CRP was analysised via the evaluate tool. Results The serum levels of HbAlc and CRP in CHD group were higher than the control group[ (4.93±8.05)mg/L vs (2.21±2.70)mg/L, (5.73±1.28) % vs (5.28±0.78)%, P 〈0.05]. Age, IX)L-C, CRP and HbAlc were related factors of CHD, CRP and ttbAlc made the highest prediction value. The serum levels of ClIP and HbAlc was positively correlated with Gensini score ( r = 0.12 - 0.15, P 〈 0.05). Conclusions Higher level of CRP and HbAlc joint detection bare significant predictive value for the seventy of coronary stenosis.
出处 《心脑血管病防治》 2013年第2期111-113,共3页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
关键词 冠心病 糖化血红蛋白 C-反应蛋白 GENSINI积分 Coronary heart disease HbAle CRP Gensini score
  • 相关文献

参考文献10

  • 1Sander D, Schulze-I-Iorn C, Bickel H, et al. Combined effects of hemoglobin Alc and C-reactive protein on the progression of subclinical carotid atherosclerosis : the INVADE study [ J ]. Stroke, 2006,37 (2) : 351 - 357.
  • 2Rivera JJ, Choi EK, Yoon YE, et al. Association between increasing lev- els of hemoglobin Alc and coronary atherosclerosis in asymptornatic indi- viduals without diabetes mellitus[ J]. Coron Artery Dis, 2010,21 (3) : 157 - 163.
  • 3Ross R. The pathogenesis of atherosclerosis: a perspective for the1990s [ J]. Nature, 1993,362(6423) : 801 - 809.
  • 4Anderson JL, Carlquist JF, Muhlestein JB, et al. Evaluation of C-reactive protein,an inflammatory marker,and infectious serology as risk factors for coronary artery disease and myocardial infarction[J]. J Am Coil Cardiol, 1998,32(1):35 -41.
  • 5Wong YK, Gallagher PJ, Ward ME. Chlamydia pneumaniae and atherosclerosis[ J]. Heart, 1999,81 (3) : 232 - 238.
  • 6Basta G, Schmidt AM, Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in dia- betes[J]. Cardiovasc Res,2004,63(4) :582 - 592.
  • 7Marfella R, Filippo C, Baldi A. The vascular smooth muscle ceils apopto- sis in asymptornatic diabetic carotid plaques: role of glycamic control[J]. J Am Coil Cardiol,2006,47(10):2118- 2120.
  • 8李军平.糖尿病血液流变学指标检测与糖化血红蛋白的相关性研究[J].苏州医学院学报,2000,20(5):460-461. 被引量:6
  • 9王丽芳,董小英,赵兴.糖尿病合并冠心病患者的糖化血红蛋白及C反应蛋白的测定及其临床意义[J].宁夏医学杂志,2006,28(9):683-684. 被引量:20
  • 10刘亚军,段梅珍,严钟德.血糖与血清C反应蛋白关系的研究[J].武警医学,2005,16(11):806-808. 被引量:1

二级参考文献14

  • 1王先令,陆菊明,潘长玉.不同糖耐量水平者血清C反应蛋白水平及阿卡波糖干预的影响[J].中华内分泌代谢杂志,2003,19(4):254-256. 被引量:43
  • 2Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 2004, 27(3): 813 - 823
  • 3Duncan BB, Schmidt MI, Pankow JS et al . Low- grade systemic inflammation and the development of type 2 diabetes: the arteriosclerosis risk in communities study. Diabetes, 2003, 52(7): 1799- 1805
  • 4Hun FB, Meigs JB, Li TY et al . Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes,2004,53(3): 693 - 700
  • 5Pradhan AD, Manson JE, Raffia N et al . C - reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001, 286(3):327-334
  • 6vlassara H,Bucala R,striker L,et al.Pathognic effects of advanced glycisylation:biochemical,and clinical implications for diabetes and aging[J].lab Invest,1994,70(2):138-151.
  • 7Wautier J L,Wautier M P,Schemidt A M,et al Advanced glycation end priducts (AGEs) On the surface of diabetic erythoxytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature:a link betweeb surface associated AGEs and diabetic complication[J].prol Nat.L Acad.Sci.USA,1994,91(16)7742-7746.
  • 8Freeman D,NorrieJ,Caslake M J,et al.Creactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland coronary prevention study[J].Diabetes,2002,51:1596-1600.
  • 9Haidari M,Javadi E,Sadeghi B,et al.Evaluation of C reactive protein,a sensitive marker of inflammation,as a risk factor for stable coronary artery disease.Clin Bioche m,2001,33:309-315.
  • 10Stern MP.Diabetes and cardiovascular disease:the"common soil"hypothesis.Diabetes,1995,44:369-374.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部